ArticlePloS one2014

Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obese-insulin resistant rats.

Nattayaporn Apaijai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.